Nicolini Andrea, Ferrari Paola, Biava Pier Mario
Department of Oncology, Transplantations and New Technologies in Medicine, University of Pisa, 56126 Pisa, Italy.
Unit of Oncology 1, Azienda Ospedaliera Universitaria Pisana, 56126 Pisa, Italy.
Cancers (Basel). 2021 Feb 16;13(4):822. doi: 10.3390/cancers13040822.
Exosomes are nano-vesicle-shaped particles secreted by various cells, including cancer cells. Recently, the interest in exosomes among cancer researchers has grown enormously for their many potential roles, and many studies have focused on the bioactive molecules that they export as exosomal cargo. These molecules can function as biomarkers in diagnosis or play a relevant role in modulating the immune system and in promoting apoptosis, cancer development and progression. Others, considering exosomes potentially helpful for cancer treatment, have started to investigate them in experimental therapeutic trials. In this review, first, the biogenesis of exosomes and their main characteristics was briefly described. Then, the capability of tumour-derived exosomes and oncosomes in tumour microenvironments (TMEs) remodelling and pre-metastatic niche formation, as well as their interference with the immune system during cancer development, was examined. Finally, the potential role of exosomes for cancer therapy was discussed. Particularly, in addition, their use as carriers of natural substances and drugs with anticancer properties or carriers of boron neutron capture therapy (BNCT) and anticancer vaccines for immunotherapy, exosomes as biological reprogrammers of cancer cells have gained increased consensus. The principal aspects and the rationale of this intriguing therapeutic proposal are briefly considered.
外泌体是由包括癌细胞在内的各种细胞分泌的纳米囊泡状颗粒。最近,癌症研究人员对外泌体的兴趣因其众多潜在作用而大幅增长,许多研究聚焦于它们作为外泌体货物输出的生物活性分子。这些分子可作为诊断中的生物标志物,或在调节免疫系统、促进细胞凋亡、癌症发展和进展中发挥相关作用。还有一些人认为外泌体可能有助于癌症治疗,已开始在实验性治疗试验中对其进行研究。在本综述中,首先简要描述了外泌体的生物发生及其主要特征。然后,研究了肿瘤衍生的外泌体和肿瘤小体在肿瘤微环境(TME)重塑和前转移生态位形成中的能力,以及它们在癌症发展过程中对免疫系统的干扰。最后,讨论了外泌体在癌症治疗中的潜在作用。特别是,除此之外,它们作为具有抗癌特性的天然物质和药物的载体,或硼中子俘获疗法(BNCT)和免疫疗法抗癌疫苗的载体,外泌体作为癌细胞的生物重编程剂已获得越来越多的共识。本文简要考虑了这一有趣治疗方案的主要方面和基本原理。